2014

Hier vindt u een chronologisch overzicht van wetenschappelijke publicaties in 2014, gepubliceerd door de klinische onderzoeksgroepen die betrokken zijn bij ATHENA/SHM.

 

The effects of HIV-1 subtype and ethnicity on CD4 decline in antiretroviral naïve patients: a Canadian-European collaborative cohort study
Klein MB, Young J, Dunn D, Ledergerber B, Sabin C, Cozzi-Lepri A, Dabis F, Harrigan R, Tan DH, Walmsley S, Gill J, Cooper C, Scherrer AU,Mocroft A, Hogg RS, Smaill F; Canadian−European Clade Collaboration.
CMAJ Open. 2014 Oct 1;2(4):E318-29. doi: 10.9778/cmajo.20140017. eCollection 2014. Abstract

Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord
Socio-economic Inequalities and HIV Writing Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
AIDS. 2014 Sep 24;28(15):2297-306. doi: 10.1097/QAD.0000000000000410. Abstract

HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
Peters L, Mocroft A, Lundgren J, Grint D, Kirk O, Rockstroh J.
BMC Infect Dis. 2014;14 Suppl 6:S13. doi: 10.1186/1471-2334-14-S6-S13. Epub 2014 Sep 19. Abstract

Deteriorating renal function and clinical outcomes in HIV-positive persons
Mocroft A, Ryom L, Begovac J, Monforte AD, Vassilenko A, Gatell J, Florence E, Ormaasen V, Kirk O, Lundgren JD; EuroSIDA in EuroCOORD.
AIDS. 2014 Mar 13;28(5):727-37. doi: 10.1097/QAD.0000000000000134. Abstract

 Increased incidence of antiretroviral drug discontinuation among patients with viremic HCV coinfection and high hyaluronic acid, a marker of liver fibrosis
Grint D1, Peters L, Rockstroh JK, de Wit S, Mitsura VM, Knysz B, Pedersen C, Kirk O, Lundgren JD, Mocroft A; EuroSIDA in EuroCoord.
AIDS. 2014 Feb 20;28(4):577-87. doi: 10.1097/QAD.0000000000000069. Abstract

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe
Podlekareva DN, Panteleev AM, Grint D, Post FA, Miro JM, Bruyand M, Furrer H, Obel N, Girardi E, Vasilenko A, Losso MH, Arenas-Pinto A, Caylá J, Rakhmanova A, Zeltina I, Werlinrud AM, Lundgren JD, Mocroft A, Kirk O; HIV/TB study group.
Eur Respir J. 2014 Jan;43(1):166-77. doi: 10.1183/09031936.00138712. Epub 2013 Jun 13. Abstract

Post-licensing safety of fosamprenavir in HIV-infected children in Europe
Judd A, Duong T, Galli L, Goetghebuer T, Ene L, Julian AN, Ramos Amador JT, Pimenta JM, Thorne C, Giaquinto C; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord.
Pharmacoepidemiol Drug Saf. 2014 Mar;23(3):321-5. Abstract

Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE inEuroCoord
Socio-economic Inequalities and HIV Writing Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
AIDS. 2014 Sep 24;28(15):2297-306. doi: 10.1097/QAD.0000000000000410. Abstract

Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs
Davies MA, May M, Bolton-Moore C, Chimbetete C, Eley B, Garone D, Giddy J, Moultrie H, Ndirangu J, Phiri S, Rabie H, Technau KG, Wood R, Boulle A, Egger M, Keiser O; IeDEA Southern Africa Collaboration.
Pediatr Infect Dis J. 2014 Jun;33(6):608-16. doi: 10.1097/INF.0000000000000214. Abstract

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, Hay P, Johnson M, Palfreeman A, Gilson R, Chadwick D, Martin F, Hill T, Walsh J, Post F, Fisher M, Ainsworth J, Jose S, Leen C, Nelson M, Anderson J, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study.
AIDS. 2014 May 15;28(8):1193-202. doi: 10.1097/QAD.0000000000000243. Abstract

Changes in HIV RNA and CD4 cell count following acute HCV infection in chronically HIV-infected individuals
Gras L, de Wolf F, Smit C, Prins M, van der Meer JT, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB; for the ATHENA national observational cohort and the MOSAIC study.
J Acquir Immune Defic Syndr. 2014 Dec 31. [Epub ahead of print] Abstract

Changes in HIV RNA and CD4 cell count following acute HCV infection in chronically HIV-infected individuals
Gras L, de Wolf F, Smit C, Prins M, van der Meer JT, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB; for the ATHENA national observational cohort and the MOSAIC study.
J Acquir Immune Defic Syndr. 2014 Dec 31. [Epub ahead of print] Abstract

A clinically useful risk-score for chronic kidney disease in HIV infection.
Mocroft A, Lundgren J, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Heuhaus J, Fux C, Moranne O, Morlat P, Johnson M, Ryom L; Data on Adverse Events (D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT study group.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19514 Abstract

Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: The AGEhIV Cohort Study.
Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P; AGEhIV Cohort Study Group.
Clin Infect Dis. 2014 Dec 15;59(12):1787-97 Abstract

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America: The ART Cohort Collaboration
Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, Costagliola D, d'Arminio A, Cavassini M, Smith C, Justice AC, Gill J, Sterne JA, Obel N.
AIDS. 2014 Nov 25 Abstract

Estimating HIV incidence from case-report data: method and an application in Colombia
Vesga JF, Cori A, van Sighem A, Hallett TB
AIDS. 2014 Nov;28 Suppl 4:S489-96. doi: 10.1097/QAD.0000000000000466 Abstract

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults
Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, Burger D, Roca B, Fehr J, Bonora S, Mocroft A, Obel N, Dauchy FA, Zangerle R, Gogos C, Gianotti N, Ammassari A, Torti C, Ghosn J, Chêne G, Grarup J, Battegay M; for the Efavirenz, Obesity Project Team the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
AIDS. 2014 Nov 25 Abstract

Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
HIV-CAUSAL Collaboration
AIDS. 2014 Oct 23;28(16):2461-73. doi: 10.1097/QAD.0000000000000456 Abstract

Increased Virological Failure in Naive HIV-1 Patients Taking Lamivudine Compared to Emtricitabine in Combination with Tenofovir and Efavirenz or Nevirapine in the Dutch Nationwide ATHENA Cohort
Rokx C, Fibriani A, van de Vijver DA, Verbon A, Schutten M, Gras L, Rijnders BJ; On behalf of the ATHENA National Observational Cohort.
Clin Infect Dis. 2014 Oct 1. pii: ciu763. [Epub ahead of print] Abstract

Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies.
Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, Keiser O, Lampe FC, Giddy J, Ndirangu J, Garone D, Fox M, Ingle SM, Reiss P, Dabis F, Costagliola D, Castagna A, Ehren K, Campbell C, Gill MJ, Saag M, Justice AC, Guest J, Crane HM, Egger M, Sterne JA.
PLoS Med. 2014 Sep 9;11(9):e1001718. doi: 10.1371/journal.pmed.1001718. eCollection 2014. Abstract

'Let's Talk about Sex': A Qualitative Study of Rwandan Adolescents' Views on Sex and HIV.
Van Nuil JI, Mutwa P, Asiimwe-Kateera B, Kestelyn E, Vyankandondera J, Pool R, Ruhirimbura J, Kanakuze C, Reiss P, Geelen SP, van de Wijgert JH, Boer KR.
PLoS One. 2014 Aug 5;9(8):e102933. doi: 10.1371/journal.pone.0102933. eCollection 2014. Abstract

A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe.
Mocroft A, Reiss P, Rakhmanova A, Banhegyi D, Phillips AN, De Wit S, Ristola M, Lundgren JD, Grarup J, Kirk O; for EuroSIDA in EuroCOORD.
Infection. 2014 Aug;42(4):757-62. doi: 10.1007/s15010-014-0630-4. Epub 2014 Jun 6. Abstract

A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy
Revell A, Boyd M, Wang D, Emery S, Gazzard B, Reiss P, van Sighem A, Montaner J, Lane H, Larder B.
HIV Med. 2014 Aug;15(7):442-8. doi: 10.1111/hiv.12156. Epub 2014 Apr 15. Abstract

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel
Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA.
JAMA. 2014 Jul 23-30;312(4):410-25. doi: 10.1001/jama.2014.8722. Abstract

Trends in underlying causes of death in people with HIV from 1999-2011 (D:A:D): a multicohort collaboration.
CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, S de Wit, M Law, W el Sadr, O Kirk, N Friis-Moller, Ad Monforte, AN Phillips, CA Sabin, JD Lundgren, D:A:D Study Group
Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8. Abstract

Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons.
Shepherd L, Souberbielle JC, Bastard JP, Fellahi S, Capeau J, Reekie J, Reiss P, Blaxhult A, Bickel M, Leen C, Kirk O, Lundgren JD, Mocroft A, Viard JP; On behalf of EuroSIDA in EuroCOORD.
J Infect Dis. 2014 Jul 15;210(2):234-43. doi: 10.1093/infdis/jiu074. Epub 2014 Feb 3. Abstract

Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients.
Ingle SM, May MT, Gill MJ, Mugavero MJ, Lewden C, Abgrall S, Fätkenheuer G, Reiss P7, Saag MS, Manzardo C, Grabar S, Bruyand M, Moore D, Mocroft A, Sterling TR, D'Arminio Monforte A, Hernando V, Teira R, Guest J, Cavassini M, Crane HM, Sterne JA; Antiretroviral Therapy Cohort Collaboration.
Clin Infect Dis. 2014 Jul 15;59(2):287-97. doi: 10.1093/cid/ciu261. Epub 2014 Apr 24. Abstract

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions
Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, Winston A, van Sighem A, Miro JM, Podzamczer D, Olson A, Arribas JR, Moreno S, Meyer L, Del Romero J, Dabis F, Bucher HC, Wandeler G, Vourli G, Skoutelis A, Lanoy E, Gasnault J, Costagliola D, Hernán MA; HIV-CAUSAL Collaboration.
Neurology. 2014 Jul 8;83(2):134-41. doi: 10.1212/WNL.0000000000000564. Epub 2014 Jun 6. PubMed PMID: 24907236. Abstract

Sexually transmitted infections, including HIV, in the Netherlands in 2013
van Aar F, Koedijk FDH, van den Broek IVF, Op de Coul ELM, Soetens LC, Woestenberg PJ, Heijne JCM, van Sighem AI, Nielen MMJ, van Benthem BHB
RIVM Rapport 150002005 Abstract

Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC).
May MT, Ingle SM, Costagliola D, Justice AC, de Wolf F, Cavassini M, D'Arminio Monforte A, Casabona J, Hogg RS, Mocroft A, Lampe FC, Dabis F, Fätkenheuer G, Sterling TR, del Amo J, Gill MJ, Crane HM, Saag MS, Guest J, Brodt HR, Sterne JA; Antiretroviral Cohort Collaboration.
Int J Epidemiol. 2014 Jun;43(3):691-702. doi: 10.1093/ije/dyt010. Epub 2013 Apr 18. Abstract

Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals.
Natural History Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
AIDS. 2014 Jun 1;28(9):1351-6. doi: 10.1097/QAD.0000000000000224. Abstract

Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations.
Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin C, El-Sadr W, d'Arminio Monforte A, Phillips A, De Wit S, Kirk O, Dabis F, Pradier C, Lundgren J, Law M; D:A:D study group.
HIV Med. 2014 May 19. doi: 10.1111/hiv.12162. [Epub ahead of print] Abstract

High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance.
Peters L, Mocroft A, Soriano V, Rockstroh J, Kirkby N, Reiss P, Katlama C, Zakharova N, Flisiak R, Lundgren J; for EuroSIDA in EuroCoord
HIV Med. 2014 May 11. doi: 10.1111/hiv.12160. [Epub ahead of print] Abstract

Long-term mortality in HIV positive individuals virally suppressed for more than three years with incomplete CD4 recovery.
Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, Monforte AD, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, De Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N; The Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Research Europe (COHERE) in EuroCoord.
Clin Infect Dis. 2014 May;58(9):1312-21. doi: 10.1093/cid/ciu038. Epub 2014 Jan 22. Abstract

A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial.
Langebeek N, Sprenger H, Gisolf E, Reiss P, Sprangers M, Legrand J, Richter C, Nieuwkerk P.
HIV Med. 2014 May;15(5):286-90. doi: 10.1111/hiv.12112. Epub 2013 Nov 11. Abstract

An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes
Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers R, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing A, Reiss P, van Sighem AI, Nelson M, Emery S, Montaner JS, Lane HC, Larder BA; on behalf of the RDI Study Group.
J Antimicrob Chemother. 2014 Apr;69(4):1104-10. doi: 10.1093/jac/dkt447. Epub 2013 Nov 24. Abstract

Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US.
The Antiretroviral Therapy Cohort Collaboration (ART-CC).
Antivir Ther. 2014 Mar 27. doi: 10.3851/IMP2768. [Epub ahead of print] Abstract

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study
Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ; D:A:D study Group.
BMC Nephrol. 2014 Mar 25;15(1):51. doi: 10.1186/1471-2369-15-51 Abstract

A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection
Mocroft A, Ryom L, Reiss P, Furrer H, D'Arminio Monforte A, Gatell J, de Wit S, Beniowski M, Lundgren J, Kirk O; for EuroSIDA in EuroCOORD. 
HIV Med. 2014 Mar;15(3):144-52. doi: 10.1111/hiv.12095. Epub 2013 Oct 3. Abstract

HIV-1 transmission networks amongst men having sex with men and heterosexuals in Kenya 
Bezemer D, Faria NR, Hassan AS, Hamers RL, Mutua G, Anzala O, Mandaliya KN, Cane PA, Berkley JA, Rinke de Wit TF, Wallis CL, Graham SM, Price MA, Coutinho R, Sanders EJ.
AIDS Res Hum Retroviruses. 2014 Feb;30(2):118-26. doi: 10.1089/AID.2013.0171. Epub 2013 Sep 17. Abstract

Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe.
Zoufaly A, Cozzi-Lepri A, Reekie J, Kirk O, Lundgren J, Reiss P, Jevtovic D, Machala L, Zangerle R, Mocroft A, Van Lunzen J; EuroSIDA in EuroCoord.
PLoS One. 2014 Jan 31;9(1):e87160. doi: 10.1371/journal.pone.0087160. eCollection 2014. Abstract

An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration.
Olson AD, Meyer L, Prins M, Thiebaut R, Gurdasani D, Guiguet M, Chaix ML, Amornkul P, Babiker A, Sandhu MS, Porter K; for C.A.S.C.A.D.E. Collaboration in EuroCoord.
PLoS One. 2014 Jan 28;9(1):e86719. doi: 10.1371/journal.pone.0086719. eCollection 2014. Abstract

Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration.
Boufassa F, Lechenadec J, Meyer L, Costagliola D, Hunt PW, Pereyra F, Deeks S, Pancino G, Taulera O, Lichterfeld M, Delobel P, Saez-Cirion A, Lambotte O; ANRS CO HIV Controllers Cohort, the Cascade Collaboration in Eurocoord, the SCOPE Cohort and the International HIV Controllers Study.
PLoS One. 2014 Jan 17;9(1):e85516. doi: 10.1371/journal.pone.0085516. eCollection 2014. Abstract

Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons.
Ryom L, Mocroft A, Kirk O, Ross M, Reiss P, Fux CA, Morlat P, Moranne O, Smith C, El-Sadr W, Law M, Lundgren JD.
AIDS. 2014 Jan 14;28(2):187-99. doi: 10.1097/QAD.0000000000000042. Abstract

Long-term Effectiveness of Combination Antiretroviral Therapy and Prevalence of HIV Drug Resistance in HIV-1-infected Children and Adolescents in Rwanda.
Mutwa PR, Boer KR, Rusine J, Muganga N, Tuyishimire D, Schuurman R, Reiss P, Lange JM, Geelen SP.
Pediatr Infect Dis J. 2014 Jan;33(1):63-9. doi: 10.1097/INF.0b013e31829e6b9f. Abstract

Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.
IeDEA and ART Cohort Collaborations
J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-e16. doi: 10.1097/QAI.0b013e3182a39979. Abstract

 
 

Stichting HIV Monitoring

Stichting HIV Monitoring (SHM) levert een belangrijke en noodzakelijke bijdrage aan de zorg voor mensen met hiv in Nederland. Door middel van het verzamelen en bewerken van gecodeerde data van hiv-positieve personen uit het hele land draagt ons monitor-onderzoek structureel bij aan de kennis over hiv en stelt het behandelend artsen in staat om de zorg voor hun patiënten continu te verbeteren. Ons jaarlijkse Monitoring Report geeft waardevolle input voor het ontwikkelen van hiv-zorg en preventiebeleid in Nederland en binnen de Europese Unie.

Bezoekadres

Nicolaes Tulphuis
Tafelbergweg 51
1105 BD Amsterdam

Postadres

Academisch Medisch Centrum
Universiteit van Amsterdam
Meibergdreef 9 1105 AZ Amsterdam

© Stichting HIV Monitoring  | Disclaimer  | Colofon